NR vs NMN: Which NAD+ Precursor Is Right For You?
NR and NMN are both effective NAD+ precursors — but they work differently, have different evidence bases, and suit different people. Our complete UK comparison guide helps you choose.
Why Is NMN Banned In The UK and Europe?
Nicotinamide Mononucleotide (NMN) has gained significant attention as a promising supplement for boosting NAD+ levels, improving metabolic health, and promoting longevity. However, in the UK and Europe, NMN has faced regulatory challenges, leading to its complex status as a supplement. But why has NMN been restricted, and what does this mean for consumers? This article explores the scientific, legal, and regulatory reasons behind the ban, the influence of global policies, and potential future developments. Is NMN banned in the UK and Europe?
Over the past decade, interest in longevity and anti-ageing science has surged, with Nicotinamide Mononucleotide (NMN) emerging as one of the most researched and promising supplements. As a precursor to Nicotinamide Adenine Dinucleotide (NAD+), NMN plays a vital role in energy metabolism, DNA repair, and overall cellular health. It has been widely embraced by those seeking to combat age-related decline, improve metabolic function, and enhance cognitive health.
Despite its growing popularity, NMN regulatory status has had a rollercoaster ride over the past few months. Consumers and researchers alike have raised questions about why NMN, a widely studied and naturally occurring compound, has been subjected to such restrictions. The ban has sparked debate over whether the decision is based on safety concerns, pharmaceutical interests, or regulatory frameworks that fail to keep pace with emerging scientific discoveries.
With increasing public interest and scientific backing, the future of NMN remains uncertain. However, understanding the regulatory landscape is essential for consumers who wish to make informed decisions about their health and longevity.
Let's Start With: What Is NMN?
Nicotinamide Mononucleotide is a naturally occurring molecule found in all living cells. It is a precursor to Nicotinamide Adenine Dinucleotide, a vital coenzyme responsible for supporting metabolism, mitochondrial function, and DNA repair. NAD+ levels naturally decline with age, leading to reduced cellular energy, impaired cognitive function, and an increased risk of age-related diseases.
How NMN Works in the Body
NMN is converted into NAD+ through a series of enzymatic reactions. By increasing NMN availability, the body can more efficiently replenish NAD+ levels, enhancing essential biological processes, including:
Energy Production – NAD+ is crucial for ATP generation in mitochondria, which fuels cellular functions.
DNA Repair – NAD+ activates sirtuins and PARPs, enzymes responsible for maintaining genomic stability.
Cognitive and Neurological Health – NAD+ supports brain cell function and neuroprotection, reducing the risk of cognitive decline.
Metabolic Regulation – Higher NAD+ levels improve insulin sensitivity, mitochondrial efficiency, and overall metabolic health.
Sources of NMN
NMN is found in small amounts in certain foods, including: broccoli, avocados, cabbage, cucumbers, tomatoes, edamame (young soybeans).
However, dietary intake alone is insufficient to produce significant increases in NAD+ levels, which is why NMN supplements gained popularity as a convenient way to enhance NAD+ production.
NMN’s Rise as a Longevity Supplement
Research on NMN has gained momentum, particularly in the field of longevity and anti-ageing science. Some of the key benefits associated with NMN supplementation include:
Increased mitochondrial function and energy levels
Enhanced muscle endurance and physical performance
Improved cognitive function and neuroprotection
Better cardiovascular health and circulation
Potential extension of lifespan through sirtuin activation
With growing scientific support, NMN became a widely used supplement in the health and wellness industry. However, regulatory challenges have since complicated its availability, leading to restrictions in regions such as the UK and Europe.
Why NMN Became a Leading Anti-Ageing Supplement
NMN’s popularity skyrocketed as research uncovered its ability to combat age-related decline. The supplement attracted widespread attention due to its potential benefits in energy production, metabolism, and longevity. Scientific interest increased as studies demonstrated NMN’s capacity to enhance mitochondrial function, improve insulin sensitivity, and activate sirtuins, proteins linked to longevity.
Scientific Studies on NMN
A number of preclinical and human trials have investigated the effects of NMN, supporting its efficacy in multiple areas of health:
Metabolism and Energy Regulation – Research published in Cell Metabolism showed that NMN supplementation improved glucose metabolism and insulin sensitivity in animal models, highlighting its potential in managing age-related metabolic decline.
Cognitive Health – A study conducted by researchers at the University of Tokyo found that NMN enhanced neuronal function and synaptic plasticity, reducing cognitive decline in aging mice.
Muscle Endurance and Physical Performance – Studies from Washington University demonstrated that NMN improved muscle function, endurance, and recovery, suggesting applications for both ageing populations and athletes.
Cardiovascular Protection – NMN was shown to improve blood vessel function, increasing nitric oxide production and reducing arterial stiffness, which are key factors in preventing cardiovascular diseases.
Influence of High-Profile Researchers
Renowned scientists, such as Dr. David Sinclair, a leading longevity researcher at Harvard Medical School, have strongly advocated for NMN as a key compound for extending healthspan. His research has helped push NMN into the public spotlight, further fueling its adoption as a supplement.
Consumer Adoption and Market Growth
With increasing awareness of NMN’s benefits, the global market for NMN supplements rapidly expanded, with major brands developing formulations aimed at boosting NAD+ levels.
Demand for Anti-Ageing Solutions – As people sought ways to enhance longevity, NMN became a staple in the longevity supplement industry.
Availability in Health and Wellness Stores – NMN supplements were widely available in markets such as the US and Asia, reinforcing its credibility and demand.
Despite this, regulatory bodies in the UK and Europe took a different stance, leading to NMN’s ban as a supplement.
With So Much Positive Research, Why Did the UK and European Regulators Ban NMN?
Regulatory Frameworks Governing Supplements in the UK and EU
The UK and European Union regulate supplements through strict guidelines to ensure consumer safety and product efficacy. These regulations primarily fall under:
- The EU Novel Food Regulation (EU) 2015/2283 – Governs new food products that have not been widely consumed in Europe before 1997, requiring safety assessments before market approval.
- The UK Novel Food Regulation – A post-Brexit adaptation of the EU framework, following similar principles in evaluating new dietary substances.
- The Medicines and Healthcare Products Regulatory Agency (MHRA, UK) – Determines whether a product should be classified as a food supplement or a medicinal product based on its effects and intended use.
Under these guidelines, NMN was classified as a Novel Food, meaning it required additional safety evaluations before it could be legally sold as a supplement.
Why NMN Was Reclassified and Restricted
Despite being sold as a supplement in various markets, NMN was flagged by regulators in the UK and EU due to its status as a novel compound with potential pharmacological effects. The key reasons for the ban include:
Lack of Sufficient Human Safety Data
- Although NMN has shown promise in animal and early-stage human studies, regulators require extensive clinical trials before approving a new compound for widespread use.
- The absence of long-term human safety data raised concerns about potential unknown risks.
Potential Pharmaceutical Classification
- The European Food Safety Authority (EFSA) and the UK’s Food Standards Agency (FSA) expressed concerns that NMN may have pharmacological properties, leading to debates over whether it should be classified as a drug rather than a supplement.
- Pharmaceutical companies have shown interest in NMN as a potential treatment for age-related diseases, which could lead to its exclusive regulation as a medicine.
The Influence of the FDA’s Decision in the US
- In 2022, the US Food and Drug Administration (FDA) ruled NMN as a drug, removing it from the list of legal dietary supplements.
- The UK and EU often align with global regulatory trends, meaning the FDA’s classification may have influenced their decision to restrict NMN.
Ongoing Novel Food Application in the EU and UK
- NMN currently has an open Novel Food application in the UK and EU, which means it may still receive approval in the future if sufficient safety data is presented.
- Until this application is approved, NMN remains banned from being legally sold as a dietary supplement.
Regulatory Controversy and Industry Pushback
The decision to ban NMN has been met with resistance from supplement manufacturers and longevity researchers. Critics argue that:
- NMN occurs naturally in the human body and food sources, making it unnecessary to classify it as a novel substance.
- Regulators may be prioritising pharmaceutical interests over consumer access to beneficial supplements.
- Consumers should have the right to access NMN based on existing scientific data, rather than waiting for prolonged regulatory approval processes.
Current Status of NMN in the UK and Europe
As of now, NMN remains restricted as a supplement in the UK and EU, but it is not outright illegal. Some companies continue to sell NMN in a legal grey area, often marketing it as a research compound rather than a dietary product.
With ongoing research and regulatory discussions, there is potential for NMN to regain approval in the future. In the next section, we will examine how the FDA’s decision in the US has played a significant role in shaping the global status of NMN.
The Influence of the FDA’s Decision on NMN on the UK and EU Ban
In late 2022, the US Food and Drug Administration (FDA) issued a ruling classifying NMN as a drug, effectively removing it from the market as a dietary supplement in the United States. This decision stemmed from NMN being investigated as a potential pharmaceutical treatment, which under US law, prevents it from being sold as a supplement if drug development occurs first.
Since regulatory agencies in the UK and EU often align their policies with the FDA, this ruling had a ripple effect on global NMN regulations, contributing to its reclassification and restriction in these regions.
Why the FDA Classified NMN as a Drug
The FDA’s decision to ban NMN from the supplement market was largely based on pharmaceutical interest in its potential therapeutic applications. NMN was being studied for its effects on age-related conditions, metabolic disorders, and cognitive decline, making it attractive for drug development. Once NMN was classified as an investigational drug, supplement manufacturers were barred from marketing it as a dietary product.
The Impact on the UK and Europe
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) and the EU’s European Food Safety Authority (EFSA) took notice of the FDA’s decision, leading them to reassess NMN’s classification. As a result:
- NMN was considered for pharmaceutical classification, rather than remaining a supplement.
- The open Novel Food application in the UK and EU gained further scrutiny.
- The supplement industry faced increased regulatory pressure to prove NMN’s safety and efficacy for non-medical use.
Did Pharmaceutical Interests Influence the Ban of NMN?
Many in the supplement and longevity community believe that the FDA’s decision, and by extension, the UK and EU’s response, were influenced by pharmaceutical interests. If NMN is classified as a drug, pharmaceutical companies gain exclusive rights to develop and distribute NMN-based treatments, potentially limiting consumer access to over-the-counter NMN supplements.
Critics argue that NMN is a naturally occurring compound found in food and human cells, which raises concerns about its reclassification as a pharmaceutical. The move to restrict NMN could set a precedent for other natural compounds being pulled from the supplement market and reserved for prescription-based distribution.
Current Legal Challenges and Industry Pushback
Since NMN’s restriction in the US, supplement manufacturers and consumer advocacy groups have been lobbying for regulatory reconsideration. Petitions and lawsuits have been filed against the FDA, questioning whether NMN should truly be classified as a drug rather than a supplement.
In the UK and EU, industry experts continue to challenge NMN’s classification, arguing that:
- There is sufficient existing safety data to allow NMN to remain on the supplement market.
- Consumers should have the right to purchase NMN for general health and wellness purposes without requiring a prescription.
- The Novel Food approval process should be expedited to bring NMN back to legal supplement status.
What’s Next for NMN in the UK and Europe?
With the ongoing Novel Food application in the UK and EU, there is still a possibility that NMN will be legally approved as a supplement. If further safety data is provided and regulators deem it fit for consumption, NMN could return to the market.
However, if NMN continues to be classified as a pharmaceutical, consumers may only be able to access it via prescription medications in the future. The debate over NMN’s classification remains a critical issue, with the outcome likely shaping the availability of other NAD+ boosters and longevity supplements.
What This Means for NMN Consumers in the UK and Europe
For consumers in the UK and EU, NMN remains in a legal grey area. While it is no longer classified as a legal supplement, it is not completely illegal to obtain. Some retailers continue to sell NMN as a “research compound”, bypassing supplement regulations, but this creates uncertainty regarding quality control and accessibility.
Consumers should be aware that:
Legally compliant retailers have stopped selling NMN as a dietary supplement.
Purchasing NMN online from international sources may be possible, but risks include customs restrictions and uncertain product quality.
Self-importing NMN carries potential legal and regulatory risks depending on individual country enforcement.
Alternatives to NMN for Boosting NAD+
With NMN no longer widely available as a supplement in the UK and Europe, consumers seeking to maintain optimal NAD+ levels can consider the following legal alternatives:
1. Nicotinamide Riboside (NR)
NR is another NAD+ precursor that remains legal and widely available. It has been studied extensively and has shown similar benefits in increasing NAD+ levels, supporting mitochondrial health, and enhancing metabolic function.
Benefits of NR:
Well-studied with strong safety data
Increases NAD+ levels effectively
Still legally available in the UK and EU
2. Niacin (Vitamin B3) and Nicotinamide
Both niacin and nicotinamide are precursors to NAD+ and can be obtained through diet or supplementation. While they may not be as efficient as NMN or NR in raising NAD+ levels, they still contribute to overall NAD+ metabolism.
Foods rich in niacin include:
Poultry (chicken, turkey)
Fish (tuna, salmon)
Mushrooms
Whole grains
Peanuts
3. Lifestyle-Based NAD+ Boosters
Certain lifestyle interventions have been shown to naturally support and maintain NAD+ levels, including:
Intermittent fasting and caloric restriction – Activates sirtuins and promotes NAD+ conservation.
Regular exercise (especially high-intensity training) – Boosts mitochondrial function and NAD+ synthesis.
Quality sleep and circadian rhythm regulation – Supports natural NAD+ production in cells.
Should Consumers Wait for NMN’s Approval?
Since NMN currently has an open Novel Food application in the UK and EU, there is a chance that regulators may eventually approve it as a supplement. However, the approval process can take years, and there are no guarantees. Consumers looking to support NAD+ levels should consider NR and lifestyle-based methods in the meantime.
While some industry experts remain optimistic about NMN’s potential return, the uncertainty surrounding its classification means that consumers must stay informed about evolving regulations and available alternatives.
The Future of NMN in the UK and Europe
The future of NMN as a supplement depends largely on the outcome of its Novel Food application in the UK and EU. If the application is approved, NMN could return to the market as a regulated food supplement. Key factors influencing approval include:
The completion of human clinical trials to provide sufficient safety data.
Regulatory acceptance of NMN’s classification as a food ingredient rather than a pharmaceutical.
Public and industry advocacy for NMN’s legalisation, demonstrating demand and consumer benefits.
Will NMN Become a Prescription Drug?
There is also the possibility that NMN will only be available as a pharmaceutical drug rather than an over-the-counter supplement. If pharmaceutical companies develop NMN-based treatments for specific conditions, such as metabolic disorders or neurodegeneration, it could be restricted for prescription use only.
This outcome would:
Increase the cost and accessibility barriers for consumers.
Restrict NMN availability to those with diagnosed medical conditions.
Limit consumer choice in using NMN for general wellness and longevity.
Industry and Consumer Advocacy Efforts
The longevity and supplement industries, along with consumer advocacy groups, continue to push for NMN’s return as a supplement. Efforts include:
Petitions and lobbying efforts urging regulators to recognise NMN’s natural presence in food and its demonstrated safety.
Legal challenges questioning the reclassification of NMN as a pharmaceutical product.
Public awareness campaigns to inform consumers about NAD+ boosters and their role in longevity science.
What Consumers Can Expect Moving Forward
The regulatory landscape surrounding NMN remains fluid, and consumers should stay informed about policy updates. Possible future outcomes include:
NMN is approved as a supplement, making it legally available again in the UK and EU.
NMN remains banned as a supplement but is developed into a prescription drug.
NMN’s status remains uncertain, with limited access through research channels and international purchases.
Until a final decision is made, consumers seeking to enhance their NAD+ levels should explore alternative NAD+ precursors like NR, dietary sources of vitamin B3, and lifestyle-based approaches to maintain cellular health.
Navigating the Future: NMN, NR, and Consumer Choices
With NMN currently restricted under novel food regulations, Nicotinamide Riboside (NR) remains the most viable and legally available NAD+ precursor in the UK and Europe. While both NMN and NR are precursors to NAD+ and have shown similar benefits in scientific research, NR has already passed the regulatory process and is approved as a novel food ingredient, making it legally available for purchase and supplementation.
Key distinctions:
NR is fully approved and regulated as a novel food, ensuring safety and quality control standards.
NMN is still under regulatory review, and while some vendors continue to sell it under research use, it remains in a grey legal area.
Both compounds increase NAD+ levels, but NR has been through more formal human trials under regulatory supervision.
Why NR Is a Reliable Alternative to NMN
Until NMN gains official approval, NR stands out as a safe and accessible alternative for those looking to maintain their NAD+ levels. Studies suggest that NR effectively increases NAD+ in humans and supports metabolic health, mitochondrial function, and cognitive longevity. Unlike NMN, NR’s approval as a novel food means it can be sold without legal uncertainty, providing consumers with a regulated option for NAD+ supplementation.
Will NMN Return to the Market?
If NMN passes its ongoing novel food application in the UK and EU, it could be reintroduced as a legally approved supplement. The key determining factors will be:
The completion of human safety trials.
Positive review outcomes from regulatory agencies such as the EFSA (European Food Safety Authority) and FSA (UK Food Standards Agency).
The extent to which pharmaceutical interests influence its classification as either a supplement or a prescription-only product.
How Consumers Can Make Informed Choices
For those looking to optimise their NAD+ levels while NMN remains restricted, the best approach is:
Use NR as a legal and scientifically supported alternative.
Incorporate natural NAD+ boosters, such as niacin-rich foods, fasting, and exercise.
Stay informed on regulatory developments, as NMN’s approval process may change in the coming years.
Conclusion: Moving Forward in the NAD+ Supplement Landscape
While NMN remains in regulatory limbo, NR continues to be a trusted and legally approved alternative for NAD+ enhancement in the UK and Europe. Consumers interested in longevity and metabolic health should turn to NR supplements, diet, and lifestyle changes to maintain optimal NAD+ levels. As NMN’s status evolves, ongoing research and industry advocacy may determine whether it will return as an accessible supplement in the future.
For now, those looking for a proven and legally compliant NAD+ booster should consider NR supplements, which are widely available and backed by regulatory approval in the UK and EU.
- £49.00Get notified This product has multiple variants. The options may be chosen on the product page
Read More Articles From NADLab.
Read More »
NAD+ and Energy: The Cellular Connection Explained
NAD+ Science NAD+ and Energy:the cellularconnection By the NADBio Team April 2025 10 min read Persistent fatigue that sleep alone can’t fix often has a
How to Naturally Boost Your NAD+ Levels
From HIIT and intermittent fasting to NR and NMN supplements, discover the most effective science-backed ways to increase your NAD+ levels and support healthy ageing.
